Thai Life Insurance Product Shift Raises Premiums Significantly

Thai Life Insurance has recently undertaken a significant strategic overhaul of its product portfolio, reorienting its focus towards endowment and whole life policies. This realignment has driven a notable increase in premium income, yet it has simultaneously placed pressure on the company’s overall profitability, according to a recent report by Maybank Securities.

Senior executives at the insurer have cautioned that near-term growth in premiums may remain limited, as market conditions stabilise and demand pressures ease. Nevertheless, earnings are expected to maintain a steady upward trajectory over the coming years, underpinned by the natural stabilisation of premium growth and improvements in claims management processes.

Within the health insurance segment, sales are anticipated to slow at the start of 2026, largely due to a high comparison base set in the previous year. In October 2025, first-time health insurance premiums fell by 43%, reflecting the impact of a co-payment policy introduced in March 2025. While this policy initially spurred sales, it subsequently caused a temporary slowdown in premium inflows.

In contrast, the company’s strategic emphasis on endowment and whole life policies has proven highly effective in boosting premium growth. Annual growth rates for these products reached 42% and 87% respectively, resulting in a 19% increase in total first-year premiums. However, these policies generally yield lower profitability than health insurance, creating margin pressures.

As a result, the company’s value of new business (VNB) margin is expected to decline to around 45% in Q4 2025, down from 57% a year earlier. Overall VNB is projected to fall by approximately 15%, to USD 0.13 billion (THB 4.1 billion), even as annual premiums rise by an estimated 8%.

Claims may remain slightly elevated, particularly due to increased incidences of influenza. Despite this, core profits in Q4 are expected to rise by around 2%, reaching approximately USD 0.087 billion (THB 2.72 billion), supported by releases from service margins on in-force contracts and profitable investment returns.

Looking further ahead, core profits for 2025 are projected to increase by roughly 10%, with annual growth rates of around 6% anticipated for 2026 and 2027. This growth is expected to be underpinned by steady health premium expansion, stable service margins on in-force contracts of USD 2.91–3.10 billion (THB 91–97 billion), and lower operational costs resulting from claims normalisation under the co-payment framework.

In summary, Thai Life Insurance’s strategic product realignment has successfully driven premium growth, yet the compression of margins reflects the delicate balance between expansion and profitability in an increasingly competitive insurance market.